The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vir Biotechnology Inc shares valued at $109,699 were sold by SATO VICKI L on Aug 01 ’25. At $4.99 per share, SATO VICKI L sold 22,000 shares. The insider’s holdings dropped to 1,276,391 shares worth approximately $6.43 million following the completion of this transaction.
Also, Eisner Mark sold 6,796 shares, netting a total of over 37,162 in proceeds. Following the sale of shares at $5.47 each, the insider now holds 108,204 shares.
Before that, Eisner Mark had sold 3,586 shares from its account. In a trade valued at $19,629, the EVP and Chief Medical Officer traded Vir Biotechnology Inc shares for $5.47 each. Upon closing the transaction, the insider’s holdings decreased to 3,586 shares, worth approximately $0.53 million.
As published in a research note from BofA Securities on August 27, 2025, Vir Biotechnology Inc [VIR] has been rated up from a Neutral to a Buy and the price target has been revised to $14. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late January. As of September 08, 2023, BofA Securities has decreased its “Buy” rating to a “Neutral” for VIR. Earlier on March 06, 2023, JP Morgan upgraded its rating. Their new recommendation was “an Overweight” for VIR stock which previously was a “a Neutral”.
Analyzing VIR Stock Performance
On last trading session, Vir Biotechnology Inc [NASDAQ: VIR] plunged -3.63% to $5.04. The stock’s lowest price that day was $5.01, but it reached a high of $5.448 in the same session. During the last five days, there has been a surge of approximately 15.07%. Over the course of the year, Vir Biotechnology Inc shares have dropped approximately -41.53%. Shares of the company reached a 52-week high of $14.45 on 01/08/25 and a 52-week low of $4.16 on 08/11/25.
Support And Resistance Levels for Vir Biotechnology Inc (VIR)
According to the 24-hour chart, there is a support level at 4.88, which, if violated, would cause prices to drop to 4.73. In the upper region, resistance lies at 5.32. The next price resistance is at 5.61. RSI (Relative Strength Index) is 55.49 on the 14-day chart, showing neutral technical sentiment.
Is Vir Biotechnology Inc subject to short interest?
Stocks of Vir Biotechnology Inc saw a sharp rise in short interest on 2025-08-15 jumping by 0.19 million shares to 11.49 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 11.29 million shares. A jump of 1.68% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.58 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.58.
Which companies own the most shares of Vir Biotechnology Inc (VIR)?
In terms of Vir Biotechnology Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, up nearly 129.45% from the previous closing price of $5.23. Analysts anticipate Vir Biotechnology Inc stock to reach 12 by 2025, with the lowest price target being 12. In spite of this, 10 analysts ranked Vir Biotechnology Inc stock as Buy at the end of 2025. On February 21, 2023, Goldman assigned a price target of “a Buy” to the stock and upgraded coverage with a $53.
